USPTO serial 79063980
HYBRIGENICS
Reviewed by CopyMark Law Group
Reg. 3731611Status 707Registered
- Filing date
- Status date
- Registration date
- Dec 29, 2009
- Examiner
- BLANE, SUZANNE
- Law office
- —
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with HYBRIGENICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeannine A Rittenhouse
Jeannine A Rittenhouse IpHorgan Ltd.195 Arlington Heights Rd.Suite #125Buffalo Grove, IL 60089Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Biological materials, namely, biological reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays for scientific or medical research; proteins intended for producing protein for therapeutic use, namely, protein arrays for scientific and medical research and therapeutic proteins for scientific use in drug discovery ] | SECTION 71 - CANCELLED | — |
| 005 | [ Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system, the cardiovascular system, the metabolic system, genito-urinary system, the musculo-skeletal system, dermatologic system, alimentary tract, sensory organs, and parasitic diseases, for the treatment of inflammatory disorders for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastrointestinal disorders; chemico-pharmaceutical preparations, namely, for use in treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; pharmaceutical products used in the treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; antibiotics, biological, biochemical and biotechnological preparations for medical purposes, chemical preparations for pharmaceutical purposes for the treatment of neurological, inflammatory, immunological, dermatological, viral, and infectious diseases, infections, parasites, cancer, neurodegenerative diseases, obesity, and diabetes; reagents in the nature of cultures of microorganisms for medical use; surgical tissues, namely, surgical implants comprising living tissue ] | SECTION 71 - CANCELLED | — |
| 009 | [ Computer programs, software and software packages, all for the scientific analysis and research used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy; interface boards for computers, apparatus for recording, transmission and reproduction of sound; data processing and computer equipment in the nature of data processors and computers, all the aforesaid goods being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy ] | SECTION 71 - CANCELLED | — |
| 035 | [ Subscription services to databases in the nature of subscription to electronic journals; database management, namely, provision of computer databases; all the aforesaid services being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy ] | SECTION 71 - CANCELLED | — |
| 038 | [ Telecommunications, namely, transmission of information via computer transmission, digital networks, electronic communications networks; and the telecommunication networks; communications by computer terminals and by means of telecommunications in the nature of communication via analogue and digital computer terminals and by satellite; transmission of information, namely, via computer networks; communications and exchange of information on a telecommunications network; computer-assisted transmission of images, data, and messages; providing multiple use access to global computer information networks for data dissemination over a telecommunications network; provision of access to databases by means of computer servers; communication by hypertext links over a telecommunications network and particularly, the Internet; providing e-mail services; data transmission services, namely, the transmission of data into electronic directories and information transmission via telecommunications networks, all the aforesaid services being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy; information exchange services over a telecommunication network, namely, information in the field of telecommunications, radio, telegraphic, telephone, and telematic communications, broadcasting of information by the way of a database on the Internet in the pharmaceutical field; rental of access time to a database server; rental of access time to a computer for the handling of data, all these services being used in biology, bioinformatics, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific and industrial research; [ the refinement of industrial processes and automation, namely, updates of industrial process control; ] professional consultancy in the fields of industrial and scientific research, namely, in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy, [ materials testing, ] laboratories in the nature of chemical, biological and medical laboratories, computer programming, all the aforesaid services being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy; industrial and scientific research in the field of molecular biology, namely, in genomics, proteomics, protein screening and research of protein interactions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks owned by HYBRIGENICS SA
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 042
- Similar marks named HYBRIGENICS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 13, 2020 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Oct 21, 2020 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Oct 21, 2020 | INPC | INVALIDATION PROCESSED | — |
| Sep 30, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 30, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jan 30, 2020 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jan 29, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 11, 2019 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Dec 29, 2018 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Apr 5, 2018 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 23, 2017 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 4, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 4, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Sep 28, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 28, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jan 28, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED | — |
| Jan 28, 2016 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jan 28, 2016 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jan 21, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jan 21, 2016 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - MAILED | — |
| Jan 21, 2016 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Jan 21, 2016 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Dec 31, 2015 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Dec 30, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Nov 18, 2015 | ES71 | TEAS SECTION 71 RECEIVED | — |
| May 18, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 26, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 26, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 29, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 29, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 13, 2009 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 13, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 10, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 8, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 25, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 25, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 25, 2009 | ALIE | ASSIGNED TO LIE | — |
| Aug 10, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 6, 2009 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 11, 2009 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 11, 2009 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 11, 2009 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 10, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2009 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 30, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 30, 2009 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 29, 2009 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |